Skip to content

Clinical trials

Dementia trials in Finland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dementia Country / region: Finland Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20061
20092
20121
20131
20141
20151
20173
20182
20192
20201
20213
20221
20234
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated6
Unknown status4
Recruiting3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Finnish Institute for Health and Welfare2
GlaxoSmithKline2
TauRx Therapeutics Ltd2
AC Immune SA1
AbbVie1
Alzinova AB1
Bristol-Myers Squibb1
GE Healthcare1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dementia27
Alzheimer Disease20
Cognitive Dysfunction14
Brain Diseases8
Nervous System Diseases6
Neurodegenerative Diseases6
Central Nervous System Diseases5
Memory Disorders5
Mental Disorders4
Tauopathies4

Trials

Showing 26 to 27 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.